AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06440564 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Er:YAG Laser irradiation
Description: The presented DALIR procedure differs in so far from a standard treatment that after exposure all accessible metal implant surfaces and the adjacent soft tissue is irradiated manually with the Er:YAG laser all over line-by-line with an intended overlap of approximately 10% at constant spot diameter.
Study NCT05150964 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Phonak Audeo hearing aid
Description: receiver in the canal devices with custom earmolds
Study NCT04941248 — intervention group
Intervention type: DEVICE
Intervention: total-body PET/CT(uEXPLORER , United Imaging Healthcare, China)
Description: This prospective study will enroll twenty-five patients, including nine healthy volunteers, sixteen patients with decreased cardiac function . All of them will have a whole-body PET/CT(uEXPLORER , United Imaging Healthcare, China) in our department, Renji Hospital.
Study NCT04652453 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Geriatrics Bundle
Description: Enrolled participants in the intervention arm will receive all 3 bundle components: occupational therapy (in addition to physical therapy) upon enrollment in the ICU, a portable amplifying device upon enrollment in the ICU, and a de-prescribing intervention by the ICU pharmacist (in conjunction with the medical team) upon ICU-to-floor transfer.
Study NCT06012903 — intervention group
Intervention type: OTHER
Intervention: Questionnaire Welbevinden
Description: A validated questionnaire recommended by the Flemish inspection of education to measure well-being in primary school children of the 4th, 5th and 6th grade.
Study NCT06012903 — intervention group
Intervention type: OTHER
Intervention: Questionnaire Vancouver symptom score for dysfunctional elimination syndrome
Description: Vancouver symptom score for dysfunctional elimination syndrome, Dutch version, validated by 't Hoen et al. 2016.
Study NCT06012903 — intervention group
Intervention type: OTHER
Intervention: Developmental Coordination Disorder Questionnaire
Description: Validated Developmental Coordination Disorder Questionnaire, Dutch version includes assessment of motor functioning.
Study NCT06012903 — intervention group
Intervention type: OTHER
Intervention: Questionnaire concerning LUTS, NDDs and treatment perceptions
Description: Unvalidated, complementary questions including the presence of LUTS, earlier diagnosis of bladder and/or boweldysfunction and neurodevelopmental disorders and perception concerning treatment characteristics.
Study NCT06012903 — intervention group
Intervention type: OTHER
Intervention: Questionnaire about policies and practices regarding children's toilet use and drinking habits in the classroom
Description: These unvalidated questionnaire was based on the questionnaire developed by Ko et al. (2016) about the school's policies and practices regarding children's toilet use and drinking habits in the classroom, covering students in grades one through six. Epidemiological questions related to LUTS were added to complement the questionnaire.
Study NCT05293353 — intervention group
Intervention type: OTHER
Intervention: NeoKare Breast Milk Fortifier
Description: Powdered product made from human breast milk used to increase nutritional content of mother's own breast milk
Study NCT04826588 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Methylprednisolone sodium succinate 10 mg/kg intravenously
Description: Methylprednisolone sodium succinate 10 mg/kg intravenously once daily for 3 days (max 1 g per dose)
Study NCT04826588 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Human normal immunoglobulin (IVIg)
Description: Human normal immunoglobulin (IVIg) 2g/kg intravenously as a single dose in line with guidance for dosing and administration in Kawasaki disease
Study NCT06181825 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: COMET-BA (Common Elements Toolbox- Behavioral Activation)
Description: COMET-BA includes 4 online weekly modules which focus on elements of behavioral activation, including positive activity scheduling, avoidance reduction, values, and change plans.
Study NCT05559996 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Injectable form of multifractional intercalated cross-linked hyaluronic acid (Armonia®, Regenyal, Italy)
Description: 2 mL of Armonia was injected into the vaginal wall with a standardized injection technique called Cannulated Intravaginal Injection Technique®. In this technique, Armonia® was injected as drops at 40 different points on the entire vaginal wall using 8 different entry points
Study NCT05556109 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Inflammatory serum biomarkers
Description: Measuring inflammatory serum biomarkers by ELISA
Study NCT05467306 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nurse-Navigator Enhanced PrEP Support
Description: Pharmacies randomized to the nurse-navigator model will receive tailored support counseling, in addition to receipt of standard PrEP services. Support counseling by nurse-navigators will provide educational messaging tailored to AGYW and actionable advice targeting PrEP persistence and adherence and/or FP topics, and will address participants' questions related to the content. Counseling will include adherence encouragement (IMB domain: motivation), PrEP efficacy and safety (IMB domain: information), self-efficacy for prevention of HIV, support for potential PrEP side effects, behavioral skills (tips for remembering PrEP medications, IMB domain: behavioral skills) and strategies for remembering PrEP refill schedules. During enrollment, the nurse-navigator will explain that support counseling is voluntary and that the nurse will also be available at the pharmacy to address concerns or questions whenever they arise outside of scheduled visits.
Study NCT05476575 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: hydrogen inhalation, 4% concentration, given via nasal cannula
Description: 4% hydrogen inhalation via nasal cannula perioperatively
Study NCT04259229 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet -- Mushrooms
Description: During the 2-week baseline period all participants will consume their usual, unrestricted self-chosen diets. During intervention weeks 1-8, all participants will consume the same Mediterranean-style diet, rich in fruits and seafoods and lower in dairy, designed to meet their estimated energy needs. The mushroom group will consume 0.5 cups/day of cooked mushrooms (white button mushrooms and yellow oyster mushrooms on 4 and 3 days/week, respectively). All foods will be provided to subjects during the intervention to achieve the desired eating pattern.
Study NCT04259229 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Mediterranean Diet -- Control
Description: During the 2-week baseline period all participants will consume their usual, unrestricted self-chosen diets. During intervention weeks 1-8, all participants will consume the same Mediterranean-style diet, rich in fruits and seafoods and lower in dairy, designed to meet their estimated energy needs. The control group will not consume mushrooms at any point. All foods will be provided to subjects during the intervention to achieve the desired eating pattern.
Study NCT06004726 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: School-based Substance abuse Prevention Programme (SSPP)
Description: Module 1 :Introduction~* Orientation about Training Programme using PowerPoint slides~* Psychoeducation and Video Assisted Teaching to enhance awareness of substance abuse.~* Distribution of informational booklet on basics about substance abuse~Module 2:~* Role play to develop a positive attitude towards the prevention of substance abuse.~* Case-based scenario to increase resistance to peer pressure.~* Demonstration of drug refusal techniques.~Module3:• Storytelling on Life skills Training Components (Problem solving, Emotion Management)~Module 4:• Demonstration of Life skills training components (Communication skills, Decision making skills, Creative thinking skills, Stress Management strategies )
Study NCT05473169 — intervention group
Intervention type: DEVICE
Intervention: Videofluoroscopy
Description: Swallowing assessment
Study NCT06246032 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Modified feeding Protocol
Description: Initiation of feeding (fixed): 10cc/kg~Advancement based on birthweight (fixed):~\<750g: 15cc/kg/d 750-999g: 20cc/kg/d 1000-1249g: 25cc/kg/d 1250-1499g: 25cc/kg/d 1500-1749g: 35cc/kg/d 1750-2000g: 35cc/kg/d~Starting Human milk fortification when feed reach at 70cc/kg/d
Study NCT04745026 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GWP42003-P
Description: GWP42003-P oral solution (100 milligrams per milliliter \[mg/mL\] cannabidiol \[CBD\] in sesame oil with anhydrous ethanol, ethanol \[10% v/v\] sweetener \[sucralose\], and strawberry flavoring), administered twice a day (morning and evening)
Study NCT04745026 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral placebo to match GWP42003-P oral solution containing sesame oil with anhydrous ethanol, sweetener (sucralose), strawberry flavoring, and beta carotene, administered twice a day (morning and evening)
Study NCT05485909 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation
Description: For multiple intrahepatic lesions, select 1 to 2 lesions for radiofrequency ablation
Study NCT05485909 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Regorafenib and Toripalimab Combination
Description: Toripalimab 200 mg, iv drip, d1, d15, q4w, Regorafenib 80mg, po, d1-d21, Q4w.
Study NCT04913896 — intervention group
Intervention type: DRUG
Intervention: PD-1 inhibitor
Description: SOX regimen for 3 cycles and/or PD-1 inhibitor before surgery
Study NCT06411366 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Follistatin plasmid
Description: Follistatin-344 plasmid
Study NCT06381063 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pain management
Description: o Pain management in both arms Intraoperative time: intravenous ketamine 0.5 mg kg-1, intravenous dexamethasone 8 mg Postoperative time: paracetamol 1 g every 6 hours a day, nefopam 20 every 8 hours a day, patient control analgesia with morphine or oxycontin
Study NCT06381063 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: pain management
Description: o Pain management in both arms Intraoperative time: intravenous ketamine 0.5 mg kg-1, intravenous dexamethasone 8 mg Postoperative time: paracetamol 1 g every 6 hours a day, nefopam 20 every 8 hours a day, patient control analgesia with morphine or oxycontin
Study NCT06381063 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ketoprofen
Description: Ketoprofen 100 mg twice a day, during 48 after surgery, intravenous administration
Study NCT06381063 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: PLacebo
Description: Placebo twice a day, during 48 h after surgery, intravenous administration
Study NCT05475353 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Asyncronized Exercise
Description: This group will be informed about ergonomics and protective exercises for the musculoskeletal system with an online seminar.
Study NCT05475353 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Syncronized Exercise
Description: This group will be informed about ergonomics and protective exercises for the musculoskeletal system with an online seminar. Then, participants will complete the 6 weeks of exercise training at an online video conference program two times a week under the physiotherapist's supervise.
Study NCT04508998 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Blood tests including genotyping
Description: Blood tests for alternative SNPs altering levels of ET-A receptor expression; blood will be further analysed for endothelin receptor mRNA and other plasma peptides important in the endothelin signalling pathway
Study NCT04508998 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Exercise Tolerance Test
Description: Treadmill exercise test using the Bruce protocol
Study NCT05991739 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Familias Inmigrantes Empoderándose contra eStrés Tomando Acción (FIESTA)
Description: FIESTA is a 10-session, group intervention led by community health workers that offers strategies related to individual stress management, family coping and communication, and community navigation.
Study NCT05991739 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Familias Inmigrantes Empoderándose contra eStrés Tomando Acción (FIESTA)
Description: FIESTA is a 10-session, group intervention led by community health workers that offers strategies related to individual stress management, family coping and communication, and community navigation.
Study NCT05209945 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: vibration
Description: whole-body vibration, heel and soleus tendon vibrations were applied to the human body
Study NCT03629093 — intervention group
Intervention type: DRUG
Intervention: General Anesthetics
Description: General anesthesia required for surgery procedures or diagnostic interventions using either intravenous or inhalation anesthetics, or both.
Study NCT05751382 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Surefil one
Description: Restorative material (Dentsply Sirona). Used for direct restoration of class V NCCL.
Study NCT05751382 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Venus Pearl
Description: Restorative material. Traditional paste composite employed in combination with iBond universal adhesive.
Study NCT05921890 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GS3-007 oral liquid
Description: The dosage was calculated according to body weight, once a day or twice a day.
Study NCT04996238 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Blood and nasal fluid sampling before and after COVID-19 vaccination
Description: Blood and nasal fluid sampling take place just before the first COVID-19 vaccination and at 14-30 days after the second dose with the same vaccine. Sampling will be repeated at 6 months after the second vaccination, at 14-30 days after the third vaccination and at 6 months after the third vaccination. At all moments, a questionnaire is filled in.
Study NCT05770726 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Probiotics administration
Description: A total of 10 grams of probiotics was administered in both group, but the routes were different. One group were per colonoscopic spray, and the other was per oral.
Study NCT04770623 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: patients with gastric cancer who have disease progression after first line treatment will receive the test protocol and evaluated for efficacy and survival
Study NCT04770623 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Irinotecan
Description: patients with gastric cancer who have disease progression after first line treatment will receive the test protocol and evaluated for efficacy and survival
Study NCT04359641 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CoMET Display
Description: Display and presentation of predictive monitoring score CoMET
Study NCT04931667 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lorecivivint
Description: Healthcare professional-administered intra-articular (IA) injection into one or both knees as clinically indicated. Bilateral injections of 0.07 mg of LOR are allowed. IA injection performed on Day 1. Additional IA injections of LOR to same knee (with at least a 6 month separation) between Day 1 and Month 33.
Study NCT04845165 — intervention group
Intervention type: OTHER
Intervention: Biopsy
Description: Biopsy of subcutaneous adipose tissue
Study NCT05823090 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: light box (Carex DayLight Classic Model)
Description: The active light box is a white fluorescent 4000 Kelvin unit that emits 10,000 lux and measures 33cm x 40cm. The placebo box emits 50 lux dim red light and appears identical to the active unit. Subjects were instructed to position themselves 30-36 cm from the box with their faces fully exposed to the light. The actigraphy device is a Phillips Spectrum Plus Actigraphy watch which collects activity level and sleep information along with multiple light measurements and wearer adherence.
Study NCT05328141 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Bread and butter
Description: A bread with butter meal without insect biomass with FeSO4 (isotopic iron 54)
Study NCT05328141 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: X.gideon
Description: Intrinsically labelled (57Fe) or non labelled X.gideon flour mixed with butter and sugar meal with FeSO4 (extrinsic label, isotopic iron 58)
Study NCT05328141 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: X.gideon with ascorbic acid
Description: Intrinsically labelled (57Fe) or non labelled X.gideon flour mixed with butter and sugar meal with FeSO4 (extrinsic label, isotopic iron 58) and ascorbic acid
Study NCT05511597 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Split-belt treadmill training
Description: Split-belt walking with various speed ratios between the two legs, applied with random-block practice
Study NCT05511597 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Split-belt treadmill training
Description: Split-belt walking with various speed ratios between the two legs, applied with random-block practice
Study NCT05511597 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Complex task practice
Description: Overground gait flexibility training with added cognitive tasks
Study NCT05511597 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Static balance exercise
Description: Mindfulness and breathing combined with static balance exercises
Study NCT05948748 — intervention group
Intervention type: PROCEDURE
Intervention: foot surgery
Description: minimally invasive osteoarticular foot surgery
Study NCT04908748 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esflurbiprofen Hydrogel Patch
Description: Esflurbiprofen is a cyclooxygenase (COX) inhibitor
Study NCT04908748 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Esflurbiprofen Hydrogel Patch
Description: Esflurbiprofen is a cyclooxygenase (COX) inhibitor
Study NCT05733572 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CHF6467
Description: drug eyedrops
Study NCT05733572 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo eyedrops
Study NCT06056388 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Straumann BLX implant
Description: Implant system with a deep fixture thread depth.
Study NCT06056388 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Straumann BLT implant
Description: Implant system with a regular fixture thread depth.
Study NCT05903326 — intervention group
Intervention type: OTHER
Intervention: Dexmedetomidine
Description: this was an observational study only based on a change of practice
Study NCT05201690 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: VV116 200 mg Group
Description: Drug: VV116 9 subjects will receive VV116 200 mg, orally, QD12h, 5.5 days ;
Study NCT05201690 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VV116 200 mg Group
Description: Drug: VV116 9 subjects will receive VV116 200 mg, orally, QD12h, 5.5 days ;
Study NCT05201690 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: VV116 400mg Group
Description: Drug: VV116 9 subjects will receive VV116 400 mg, orally, QD12h, 5.5 days ;
Study NCT05201690 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VV116 400mg Group
Description: Drug: VV116 9 subjects will receive VV116 400 mg, orally, QD12h, 5.5 days ;
Study NCT05201690 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: VV116 600mg Group
Description: Drug: VV116 9 subjects will receive VV116 600 mg, orally, QD12h, 5.5 days ;
Study NCT05201690 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VV116 600mg Group
Description: Drug: VV116 9 subjects will receive VV116 600 mg, orally, QD12h, 5.5 days ;
Study NCT06526962 — intervention group
Intervention type: DEVICE
Intervention: 5Fr hysteroscopic bipolar electrode or conical optical 5Fr fibers for dual wave-length diode laser
Description: Outpatient hysteroscopic polypectomy
Study NCT06395857 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Visual arts-based intervention
Description: This visual arts-based intervention is grounded on Bandura's Self-Efficacy Theory. It consists of four weekly group and face-to-face sessions delivered by a qualified facilitator. The contents of the intervention involve structured visual art-making activity, group discussion, and workbook assistance.
Study NCT05113056 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Acutus Medical Pulsed Field Ablation System
Description: All subjects will be treated using the Acutus Medical Pulsed Field Ablation System (PFA System) to treat their atrial fibrillation.
Study NCT04940455 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational digital platforms
Description: The digital educational platforms will be implemented through games of questions and answers, simulated cases sent via google forms about the nurse's performance in a critical care unit facing the patient with signs and symptoms of sepsis. The questions in the games will aim to develop clinical judgment and quick decision-making in nursing students in order not to compromise the health care of the patient in sepsis.
Study NCT04940455 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Educational digital platforms
Description: The digital educational platforms will be implemented through games of questions and answers, simulated cases sent via google forms about the nurse's performance in a critical care unit facing the patient with signs and symptoms of sepsis. The questions in the games will aim to develop clinical judgment and quick decision-making in nursing students in order not to compromise the health care of the patient in sepsis.